In vitro percutaneous absorption of piroxicam through synthetic membranes and abdominal rat skin

Pharmaceutica Acta Helvetiae

Volumn 71, Issue 2, 1996, Pages 141-146

  Santoyo, S ^a   Arellano, A ^a   Ygartua, P ^a   Martin C ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Gel formulation; Percutaneous absorption; Piroxicam; Release rate

Indexed keywords

CARBOMER; MYRISTIC ACID ISOPROPYL ESTER; PIROXICAM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG RELEASE; IN VITRO STUDY; MALE; MEMBRANE MODEL; NONHUMAN; PHYSICAL CHEMISTRY; RAT; SKIN ABSORPTION; SKIN PENETRATION; SOLUBILITY; ULTRAVIOLET SPECTROPHOTOMETRY; VISCOSITY;

EID: 0030198010     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/0031-6865(96)00004-0     Document Type: Article

References (12)

1. Al-Khamis, K., Davis, S.S. and Hadgraft, J. (1986). Microviscosity and drug release from topical gel formulations. Pharm. Res. 3, 214-217.
2. Barry, B.W. (1983). Properties that influence percutaneous absorption. In Barry B.W. (Ed), Dermatological formulations. Percutaneous absorption. Marcel Dekker Inc., New York, pp. 191-194.
3. Bottari, F., Di Colo, G., Nannipieri, E., Saettone, M.F. and Saerfini, M.F. (1974). Influence of drug concentration on in vitro release of salicylic acid from ointment bases. J. Pharm. Sci. 63, 1779-1783.
4. Guy, R.H. and Hadgraft, J. (1990). On the determination of drug release rates from topical dosage forms. Int. J. Pharm. 60, R1-R3.
5. Hadgraft, J. and Ridout, G. (1987). Developement of model membranes for percutaneous absorption measurements. I. Isopropyl myristate. Int. J. Pharm. 39, 149-156.
6. Hadgraft, J. (1989). Formulation of anti-inflammatory agents. In Hensby, C. and Lowe, N.J. (Eds), Nonsteroidal anti-inflammatory drugs. Kargel, Basel, pp. 21-43.
7. Higuchi, W.I. (1962). Analysis data on the medicament release from ointments J. Pharm. Sci. 51, 802-804.
8. Idson, B. (1975). Percutaneous absorption. J. Pharm. Sci. 64, 901-924.
9. Poulsen, B.J., Young, E., Coquilla, V. and Kartz, M. (1968). Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester. J. Pharm. Sci. 57, 928-933.
10. Schiantarelli, P. and Cadel, S. (1981). Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route. Arzneim.-Forsch. Drug Res. 31, 87-92.
11. Schiantarelli, P., Cadel, S., Acerbi, D. and Pavesi, L. (1982). Antiinflammatory activity and bioavailability of percutaneous piroxicam. Arzneim.-Forsch. Drug Res. 32, 230-235.
12. Shima, K., Matsuska, C., Hirose, M., Noguchi, T. and Yamahira, Y. (1981). Biopharmaceutical characteristics of indometacin gel ointment. Chem. Pharm. Bull. 29, 2338-2343.